Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences: Mark Stenhouse, Pat Setji

Exact Sciences announced that Mark Stenhouse left his position as general manager of the company's screening business on Jan. 5. He will be succeeded by Pat Setji, Exact's vice president of business operations.

Over the last 20 years Setji has served in multiple sales and marketing leadership roles at Pfizer, Eli Lilly, and Exact. In connection with his departure, Stenhouse will assist with the transition as an advisor, and will remain with Exact as a non-executive employee through March 31.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.